We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+18.78%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.66B
AUM Growth
+$275M
Cap. Flow
+$68.7M
Cap. Flow %
4.14%
Top 10 Hldgs %
23.67%
Holding
233
New
36
Increased
109
Reduced
61
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 32.93%
2 Healthcare 19.82%
3 Industrials 15.24%
4 Consumer Discretionary 9.82%
5 Consumer Staples 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
126
Intellia Therapeutics
NTLA
$1.67B
$3.3M 0.2%
120,645
+10,203
+9% +$247K
PRLB icon
127
Protolabs
PRLB
$2.13B
$3.27M 0.2%
27,500
+250
+0.9% +$30.6K
CCOI icon
128
Cogent Communications
CCOI
$508M
$3.26M 0.2%
61,110
+30,732
+101% +$1.53M
NXST icon
129
Nexstar Media Group
NXST
$5.97B
$3.24M 0.2%
44,103
-14,361
-25% -$971K
CYRX icon
130
CryoPort
CYRX
$762M
$3.21M 0.19%
203,343
+27,749
+16% +$295K
AFH
131
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$3.06M 0.18%
349,284
+71,802
+26% +$763K
COLL icon
132
Collegium Pharmaceutical
COLL
$956M
$3.04M 0.18%
127,460
+83,860
+192% +$2.06M
LXFR icon
133
Luxfer Holdings
LXFR
$458M
$3.02M 0.18%
+172,806
New +$2.77M
REI icon
134
Ring Energy
REI
$339M
$3.01M 0.18%
238,621
+69,330
+41% +$1.01M
HTGM
135
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2.98M 0.18%
5,086
+628
+14% +$410K
GTT
136
DELISTED
GTT Communications, Inc.
GTT
$2.9M 0.18%
64,554
+25,971
+67% +$1.29M
IPGP icon
137
IPG Photonics
IPGP
$3.84B
$2.85M 0.17%
12,922
+400
+3% +$94.4K
IOTS
138
DELISTED
Adesto Technologies Corp
IOTS
$2.84M 0.17%
338,132
+263,265
+352% +$2.31M
WAGE
139
DELISTED
WageWorks, Inc.
WAGE
$2.82M 0.17%
56,425
+31,708
+128% +$1.45M
EDIT icon
140
Editas Medicine
EDIT
$442M
$2.78M 0.17%
77,555
+6,549
+9% +$232K
VG
141
DELISTED
Vonage Holdings Corporation
VG
$2.66M 0.16%
206,043
-16,643
-7% -$191K
TER icon
142
Teradyne
TER
$59.3B
$2.65M 0.16%
69,514
+7,327
+12% +$286K
LQDT icon
143
Liquidity Services
LQDT
$1.32B
$2.61M 0.16%
398,641
-42,521
-10% -$259K
AUTL
144
Autolus Therapeutics
AUTL
$562M
$2.61M 0.16%
+97,415
New +$2.57M
ITRM
145
DELISTED
Iterum Therapeutics
ITRM
$2.57M 0.15%
+16,057
New +$2.9M
WGO icon
146
Winnebago Industries
WGO
$909M
$2.57M 0.15%
63,311
+36,891
+140% +$1.41M
PFPT
147
DELISTED
Proofpoint, Inc.
PFPT
$2.53M 0.15%
21,975
-2,873
-12% -$349K
PFIE
148
DELISTED
Profire Energy, Inc
PFIE
$2.52M 0.15%
744,366
+144,315
+24% +$583K
NEWR
149
DELISTED
New Relic, Inc.
NEWR
$2.51M 0.15%
24,972
+3,103
+14% +$276K
XERS icon
150
Xeris Biopharma Holdings
XERS
$1.45B
$2.48M 0.15%
+130,700
New +$2.54M

Similar funds

Granahan Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Granahan Investment Management held 233 positions worth $1.66B, up 20% from $1.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management deployed $68.7M of net new capital in Q2 2018, opening 36 new positions and adding to 109 existing holdings. Its largest new stake was Globant: 437,078 shares worth $24.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Teladoc Health, an estimated $10.8M trimmed.

  • Granahan Investment Management's largest Q2 2018 buy was Globant: 437,078 shares worth $24.8M.
  • Granahan Investment Management added most to WW International in Q2 2018, an estimated $23.8M increase.
  • Granahan Investment Management's biggest Q2 2018 reduction was Teladoc Health, cutting an estimated $10.8M.
  • Granahan Investment Management fully exited MINDBODY, Inc. Class A Common Stock in Q2 2018, selling an estimated $9.71M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.66B portfolio in Q2 2018.
  • Granahan Investment Management opened 36 new positions and closed 26 in Q2 2018.
  • Granahan Investment Management's portfolio value rose 20% quarter-over-quarter to $1.66B.

Based on Granahan Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.